Flagship Biosciences to present quantitative tissue-based data on five clinical trial and immuno-oncology topics at AACR

Back to News

Flagship Biosciences’ Computational Tissue Analysis (cTA™) and decision support platform featured in five scientific poster presentations at the American Association for Cancer Research Annual Meeting, April 1-5, 2017, in Washington, D.C. Visit Flagship at @AACR booth #1553 and learn more about the posters at BioSpace.

Share this Post: